Know-How and expanded Capacity to Advance Sterile Products

Published on: 

Sponsored Content

Discover how Pii’s expanded aseptic processing capabilities and capacity can bring greater efficiency, flexibility, and reliability to the development of your sterile drug product.

Pii offers product development and cGMP manufacturing services for dosage forms including steriles, liquids, semi-solids, and oral solids, applying more than 25 years of scientific know-how, regulatory filing experience, and deep commitment to customer relationships. 

 

Recognizing the growing need for flexible aseptic production systems that can efficiently process high-quality, medium-sized clinical and commercial batches, we have expanded our capabilities and capacity with investment in a new, fully-robotic aseptic filling line. With the addition of the GENiSYS® R filling machine, we can process pre-sterilized, ready-to-fill vials, syringes, and cartridges on a single machine, delivering greater speed, efficiency, and flexibility in aseptic, toxic, and cytotoxic drug products.

 

This latest expansion in our portfolio of services reflects our constant commitment to delivering high-quality sterile drug product for customers on aggressive timelines. Discover how our depth of experience, know-how, and integrity as a CDMO partner can optimize the development of your sterile product.

 

Pii
10819 Gilroy Road
Hunt Valley, Maryland 21031 USA
tel. +1 410 584 0001
bd@pharm-int.com
www.pharm-int.com